These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 2619361

  • 1. Antileishmanial effects of clofazimine and other antimycobacterial agents.
    Evans AT, Croft SL, Peters W, Neal RA.
    Ann Trop Med Parasitol; 1989 Oct; 83(5):447-54. PubMed ID: 2619361
    [Abstract] [Full Text] [Related]

  • 2. The activity of plumbagin and other electron carriers against Leishmania donovani and Leishmania mexicana amazonensis.
    Croft SL, Evans AT, Neal RA.
    Ann Trop Med Parasitol; 1985 Dec; 79(6):651-3. PubMed ID: 3834847
    [No Abstract] [Full Text] [Related]

  • 3. The activity of nitrofurazone and furazolidone against Leishmania donovani, L. major and L. enriettii in vitro and in vivo.
    Neal RA, van Bueren J, Hooper G.
    Ann Trop Med Parasitol; 1988 Oct; 82(5):453-6. PubMed ID: 2855778
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG, Mendonça DVC, Tavares GSV, Lage DP, Dias DS, Ribeiro PAF, Perin L, Ludolf F, Coelho VTS, Ferreira ACG, Neves PHAS, Matos GF, Chávez-Fumagalli MA, Coimbra ES, Pereira GR, Coelho EAF, Antinarelli LMR.
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
    Nieto-Meneses R, Castillo R, Hernández-Campos A, Maldonado-Rangel A, Matius-Ruiz JB, Trejo-Soto PJ, Nogueda-Torres B, Dea-Ayuela MA, Bolás-Fernández F, Méndez-Cuesta C, Yépez-Mulia L.
    Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and pharmacological evaluation of mono-arylimidamides as antileishmanial agents.
    Zhu X, Farahat AA, Mattamana M, Joice A, Pandharkar T, Holt E, Banerjee M, Gragg JL, Hu L, Kumar A, Yang S, Wang MZ, Boykin DW, Werbovetz KA.
    Bioorg Med Chem Lett; 2016 May 15; 26(10):2551-2556. PubMed ID: 27048943
    [Abstract] [Full Text] [Related]

  • 7. Herbicides to curb human parasitic infections: in vitro and in vivo effects of trifluralin on the trypanosomatid protozoans.
    Chan MM, Grogl M, Chen CC, Bienen EJ, Fong D.
    Proc Natl Acad Sci U S A; 1993 Jun 15; 90(12):5657-61. PubMed ID: 8516314
    [Abstract] [Full Text] [Related]

  • 8. Antileishmanial activity of a series of N²,N⁴-disubstituted quinazoline-2,4-diamines.
    Van Horn KS, Zhu X, Pandharkar T, Yang S, Vesely B, Vanaerschot M, Dujardin JC, Rijal S, Kyle DE, Wang MZ, Werbovetz KA, Manetsch R.
    J Med Chem; 2014 Jun 26; 57(12):5141-56. PubMed ID: 24874647
    [Abstract] [Full Text] [Related]

  • 9. 3'-Deoxy-3'-fluoroinosine as a potent antileishmanial agent. The metabolism and selective cytotoxic effect of 3'-deoxy-3'-fluoroinosine against Leishmania tropica and L. donovani in vitro and in vivo.
    Shin IS, Tanifuji H, Arata Y, Morizawa Y, Nakayama T, Wataya Y.
    Parasitol Res; 1995 Jun 26; 81(7):622-6. PubMed ID: 7479655
    [Abstract] [Full Text] [Related]

  • 10. Hydrazide antidepressants possess novel antileishmanial activity in vitro and in vivo.
    Evans AT, Croft SL, Peters W, Neal RA.
    Ann Trop Med Parasitol; 1989 Feb 26; 83(1):19-24. PubMed ID: 2596901
    [Abstract] [Full Text] [Related]

  • 11. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species.
    Valadares DG, Duarte MC, Oliveira JS, Chávez-Fumagalli MA, Martins VT, Costa LE, Leite JP, Santoro MM, Régis WC, Tavares CA, Coelho EA.
    Parasitol Int; 2011 Dec 26; 60(4):357-63. PubMed ID: 21723957
    [Abstract] [Full Text] [Related]

  • 12. Topical treatment of New and Old World cutaneous leishmaniasis in experimental animals.
    el-On J, Hamburger AD.
    Trans R Soc Trop Med Hyg; 1987 Dec 26; 81(5):734-7. PubMed ID: 3449988
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo prophylactic and curative activity of the triterpene saponin PX-6518 against cutaneous Leishmania species.
    Inocêncio da Luz RA, Vermeersch M, Deschacht M, Hendrickx S, Van Assche T, Cos P, Maes L.
    J Antimicrob Chemother; 2011 Feb 26; 66(2):350-3. PubMed ID: 21131319
    [Abstract] [Full Text] [Related]

  • 14. Investigation of antileishmanial activities of Tio2@Ag nanoparticles on biological properties of L. tropica and L. infantum parasites, in vitro.
    Allahverdiyev AM, Abamor ES, Bagirova M, Baydar SY, Ates SC, Kaya F, Kaya C, Rafailovich M.
    Exp Parasitol; 2013 Sep 26; 135(1):55-63. PubMed ID: 23792003
    [Abstract] [Full Text] [Related]

  • 15. Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous leishmaniasis and visceral leishmaniasis.
    Al-Abdely HM, Graybill JR, Bocanegra R, Najvar L, Montalbo E, Regen SL, Melby PC.
    Antimicrob Agents Chemother; 1998 Oct 26; 42(10):2542-8. PubMed ID: 9756753
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV, Mendonça DVC, Lage DP, Antinarelli LMR, Soyer TG, Senna AJS, Matos GF, Dias DS, Ribeiro PAF, Batista JPT, Poletto JM, Brandão GC, Chávez-Fumagalli MA, Pereira GR, Coimbra ES, Coelho EAF.
    Acta Trop; 2019 Mar 26; 191():29-37. PubMed ID: 30586571
    [Abstract] [Full Text] [Related]

  • 17. Antigen recognition by effector T cells in antileishmanial defense.
    Sypek JP, Panosian CB, Wyler DJ.
    J Infect Dis; 1985 Nov 26; 152(5):1057-63. PubMed ID: 2413143
    [Abstract] [Full Text] [Related]

  • 18. SQ109 inhibits proliferation of Leishmania donovani by disruption of intracellular Ca2+ homeostasis, collapsing the mitochondrial electrochemical potential (ΔΨm) and affecting acidocalcisomes.
    Gil Z, Martinez-Sotillo N, Pinto-Martinez A, Mejias F, Martinez JC, Galindo I, Oldfield E, Benaim G.
    Parasitol Res; 2020 Feb 26; 119(2):649-657. PubMed ID: 31897791
    [Abstract] [Full Text] [Related]

  • 19. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M, dos Reis Lage LM, Lage DP, Mesquita JT, Salles BC, Lavorato SN, Menezes-Souza D, Roatt BM, Alves RJ, Tavares CA, Tempone AG, Coelho EA.
    Vet Parasitol; 2016 Feb 15; 217():81-8. PubMed ID: 26827866
    [Abstract] [Full Text] [Related]

  • 20. The sensitivity of Leishmania species to aminosidine.
    Neal RA, Allen S, McCoy N, Olliaro P, Croft SL.
    J Antimicrob Chemother; 1995 May 15; 35(5):577-84. PubMed ID: 7592170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.